OTCPK:SCVM

Stock Analysis Report

Executive Summary

Scivanta Medical Corporation does not have significant operations.

Snowflake

Fundamentals

Adequate balance sheet with weak fundamentals.

Risks

  • Scivanta Medical has significant price volatility in the past 3 months.
  • Scivanta Medical's last earnings update was 1065 days ago.
  • Scivanta Medical is not covered by any analysts.

Share Price & News

How has Scivanta Medical's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

OTCPK:SCVM

0.8%

US Medical Equipment

1.1%

US Market


1 Year Return

n/a

OTCPK:SCVM

9.6%

US Medical Equipment

2.1%

US Market

No trading data on SCVM.

No trading data on SCVM.


Share holder returns

SCVMIndustryMarket
7 Day0%0.8%1.1%
30 Day42.9%0.2%3.7%
90 Day25.0%2.7%2.3%
1 Yearn/a10.5%9.6%4.4%2.1%
3 Year6.4%6.4%69.5%64.3%47.0%37.4%
5 Year-61.5%-61.5%132.5%105.9%61.6%43.8%

Price Volatility Vs. Market

How volatile is Scivanta Medical's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Scivanta Medical undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether Scivanta Medical is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Scivanta Medical has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Examine Scivanta Medical's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Scivanta Medical regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is Scivanta Medical expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

22.6%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Scivanta Medical has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has Scivanta Medical performed over the past 5 years?

0.2%

Historical Healthcare annual earnings growth


In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Scivanta Medical has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Next Steps

Financial Health

How is Scivanta Medical's financial position?


In this section we usually analyse Scivanta Medical's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Scivanta Medical has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Next Steps

  • Take a look at our analysis of SCVM’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website.
  • Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when Scivanta Medical's financial data was last updated here.
  • Explore more healthy companies in the Healthcare industry.

Dividend

What is Scivanta Medical's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Scivanta Medical's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Scivanta Medical's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Scivanta Medical has not reported any payouts.

Unable to verify if Scivanta Medical's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Scivanta Medical has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Scivanta Medical's salary, the management and board of directors tenure and is there insider trading?

16.4yrs

Average management tenure


CEO

David LaVance (65yo)

16.4yrs

Tenure

0

Mr. David R. LaVance, Jr., J.D., served as a Partner and Venture Partner at Allegory Venture Partners, LLC. Mr. LaVance has been the Chairman and Chief Executive Officer of Scivanta Medical Corporation sin ...


CEO Compensation Analysis

Insufficient data for David to establish whether their remuneration is reasonable compared to companies of similar size in United States of America.

Insufficient data for David to compare compensation growth.


Management Age and Tenure

16.4yrs

Average Tenure

50yo

Average Age

The average tenure for the Scivanta Medical management team is over 5 years, this suggests they are a seasoned and experienced team.


Board Age and Tenure

16.4yrs

Average Tenure

53yo

Average Age

The average tenure for the Scivanta Medical board of directors is over 10 years, this suggests they are a seasoned and experienced board.


Insider Trading

No 3 month open market individual insider trading information.


Management Team

  • David LaVance (65yo)

    Chairman & CEO

    • Tenure: 16.4yrs
  • Tom Gifford (50yo)

    CFO, Principal Accounting Officer

    • Tenure: 16.4yrs
  • Leonard Lovallo (38yo)

    President

    • Tenure: 1.3yrs

Board Members

  • David LaVance (65yo)

    Chairman & CEO

    • Tenure: 16.4yrs
  • Tom Gifford (50yo)

    CFO, Principal Accounting Officer

    • Tenure: 16.4yrs
  • Anthony Giordano (53yo)

    Independent Director

    • Tenure: 12.4yrs

Company Information

Scivanta Medical Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Scivanta Medical Corporation
  • Ticker: SCVM
  • Exchange: OTCPK
  • Founded: 1981
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$1.047m
  • Shares outstanding: 20.93m
  • Website: https://www.scivanta.com

Number of Employees


Location

  • Scivanta Medical Corporation
  • 215 Morris Avenue
  • Spring Lake
  • New Jersey
  • 7762
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
SCVMOTCPK (Pink Sheets LLC)YesCommon StockUSUSDFeb 1998

Biography

Scivanta Medical Corporation does not have significant operations. Previously, it was engaged in the development, manufacture, and distribution of the Scivanta cardiac monitoring system. The company intend ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/08/14 23:53
End of Day Share Price2019/07/31 00:00
Earnings2016/07/31
Annual Earnings2015/10/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.